Management of hyperglycemia during acute stroke

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Long-term complications of hyperglycemia are well known, but short-term complications are not. Because hyperglycemia and hypoglycemia can be corrected relatively rapidly, it seems important to determine if such interventions during acute illnesses improve patient outcomes. In most animal stroke studies, animals with hyperglycemia before or during brain ischemia have worse outcomes than those with normoglycemia. In humans, hyperglycemia during acute stroke has been associated with worse clinical outcomes than normoglycemia, but it remains to be established if rapid correction of the hyperglycemia will improve patient outcomes. Intravenous insulin infusion protocols are the only currently established methods to effectively lower and control hyperglycemia during acute illness. Recent pilot clinical trials demonstrate feasibility and safety of such interventions. One randomized efficacy trial has been reported and additional trials are needed. In the meantime, an intermediate approach to managing acute stroke hyperglycemia with subcutaneous insulin seems reasonable.

Original languageEnglish (US)
Pages (from-to)36-41
Number of pages6
JournalCurrent Cardiology Reports
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Hyperglycemia
Stroke
Insulin
Brain Ischemia
Hypoglycemia
Intravenous Infusions
Clinical Trials
Safety

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of hyperglycemia during acute stroke. / Bruno, Askiel.

In: Current Cardiology Reports, Vol. 11, No. 1, 01.01.2009, p. 36-41.

Research output: Contribution to journalArticle

@article{eb1aaa33738647b8a91c77d38f073b07,
title = "Management of hyperglycemia during acute stroke",
abstract = "Long-term complications of hyperglycemia are well known, but short-term complications are not. Because hyperglycemia and hypoglycemia can be corrected relatively rapidly, it seems important to determine if such interventions during acute illnesses improve patient outcomes. In most animal stroke studies, animals with hyperglycemia before or during brain ischemia have worse outcomes than those with normoglycemia. In humans, hyperglycemia during acute stroke has been associated with worse clinical outcomes than normoglycemia, but it remains to be established if rapid correction of the hyperglycemia will improve patient outcomes. Intravenous insulin infusion protocols are the only currently established methods to effectively lower and control hyperglycemia during acute illness. Recent pilot clinical trials demonstrate feasibility and safety of such interventions. One randomized efficacy trial has been reported and additional trials are needed. In the meantime, an intermediate approach to managing acute stroke hyperglycemia with subcutaneous insulin seems reasonable.",
author = "Askiel Bruno",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s11886-009-0006-z",
language = "English (US)",
volume = "11",
pages = "36--41",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Management of hyperglycemia during acute stroke

AU - Bruno, Askiel

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Long-term complications of hyperglycemia are well known, but short-term complications are not. Because hyperglycemia and hypoglycemia can be corrected relatively rapidly, it seems important to determine if such interventions during acute illnesses improve patient outcomes. In most animal stroke studies, animals with hyperglycemia before or during brain ischemia have worse outcomes than those with normoglycemia. In humans, hyperglycemia during acute stroke has been associated with worse clinical outcomes than normoglycemia, but it remains to be established if rapid correction of the hyperglycemia will improve patient outcomes. Intravenous insulin infusion protocols are the only currently established methods to effectively lower and control hyperglycemia during acute illness. Recent pilot clinical trials demonstrate feasibility and safety of such interventions. One randomized efficacy trial has been reported and additional trials are needed. In the meantime, an intermediate approach to managing acute stroke hyperglycemia with subcutaneous insulin seems reasonable.

AB - Long-term complications of hyperglycemia are well known, but short-term complications are not. Because hyperglycemia and hypoglycemia can be corrected relatively rapidly, it seems important to determine if such interventions during acute illnesses improve patient outcomes. In most animal stroke studies, animals with hyperglycemia before or during brain ischemia have worse outcomes than those with normoglycemia. In humans, hyperglycemia during acute stroke has been associated with worse clinical outcomes than normoglycemia, but it remains to be established if rapid correction of the hyperglycemia will improve patient outcomes. Intravenous insulin infusion protocols are the only currently established methods to effectively lower and control hyperglycemia during acute illness. Recent pilot clinical trials demonstrate feasibility and safety of such interventions. One randomized efficacy trial has been reported and additional trials are needed. In the meantime, an intermediate approach to managing acute stroke hyperglycemia with subcutaneous insulin seems reasonable.

UR - http://www.scopus.com/inward/record.url?scp=63249095590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63249095590&partnerID=8YFLogxK

U2 - 10.1007/s11886-009-0006-z

DO - 10.1007/s11886-009-0006-z

M3 - Article

C2 - 19091173

AN - SCOPUS:63249095590

VL - 11

SP - 36

EP - 41

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 1

ER -